Last updated: May 29, 2026

Application No. 17/308,555

ARTICLE INCLUDING PHTHALOCYANINE DYES

Final Rejection

Filed

May 05, 2021

Priority

Dec 21, 2018 — continuation of 16/230,451

Examiner

MCDOWELL, BRIAN E

Art Unit

1624

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

VIAVI SOLUTIONS INC.

OA Round

4 (Final)

Interview Optional

— +30.6% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 74% grant rate with +30.6% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 1111 resolved cases, 2023–2026

Examiner Intelligence

MCDOWELL, BRIAN E View full profile →

Grants 74% — above average

Career Allowance Rate

825 granted / 1111 resolved

+14.3% vs TC avg

Strong +31% interview lift

Without

With

+30.6%

Interview Lift

resolved cases with interview

Typical timeline

2y 2m

Avg Prosecution

47 currently pending

Career history

1169

Total Applications

across all art units

Statute-Specific Performance

§101

0.3%

-39.7% vs TC avg

§103

23.5%

-16.5% vs TC avg

§102

19.1%

-20.9% vs TC avg

§112

51.1%

+11.1% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1111 resolved cases

Prosecution Timeline

Show 5 earlier events

Sep 05, 2024

Request for Continued Examination

Sep 06, 2024

Response after Non-Final Action

Oct 22, 2024

Non-Final Rejection mailed

Feb 24, 2025

Response Filed

Jun 02, 2025

Response Filed

Jun 02, 2025

Examiner Interview Summary

Jun 02, 2025

Applicant Interview (Telephonic)

Dec 01, 2025

Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/590,749

Patent 12636371

Chemically Coupled Transporter for Low-Hydrophobicity Bioactive Drugs into the Central Nervous System

2y 2m to grant Granted May 26, 2026

18/196,601

Patent 12617782

PYRIDAZINONES AS PARP7 INHIBITORS

2y 11m to grant Granted May 05, 2026

19/223,498

Patent 12617774

SUBSTITUTED INDOLE COMPOUNDS AND METHODS OF USE THEREOF

11m to grant Granted May 05, 2026

17/575,898

Patent 12612381

CRYSTALLINE FORMS OF N-(4-(4-(CYCLOPROPYLMETHYL)PIPERAZINE-1-CARBONYL)PHENYL)QUINOLINE-8-SULFONAMIDE

4y 3m to grant Granted Apr 28, 2026

17/801,551

Patent 12606556

TYK-2 INHIBITOR

3y 8m to grant Granted Apr 21, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6

Expected OA Rounds

74%

Grant Probability

99%

With Interview (+30.6%)

2y 2m (~0m remaining)

Median Time to Grant

High

PTA Risk

Based on 1111 resolved cases by this examiner. Grant probability derived from career allowance rate.

ARTICLE INCLUDING PHTHALOCYANINE DYES

Interview Optional

Examiner Intelligence

Statute-Specific Performance

Prosecution Timeline

Precedent Cases

Applications granted by this same examiner with similar technology

Strategy Recommendation AI-generated — please review before filing

Prosecution Projections

Ready to respond to this office action?

Sign in with your work email